An Award-Winning Year: A Look Back at 2024

It’s been another pivotal year at Enable Injections, including several exciting announcements and awards to continue our momentum into 2025.

As the year draws to a close, it’s easy to forget some of the milestones from earlier in the year. Before we fully focus on the year ahead and beyond, here’s a look back at 2024:

• • New and Expanded Partnerships:
    • Serina Therapeutics: Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination with enFuse® for Advanced Parkinson’s Disease
    • Roche: Enable Injections Expands Strategic Partnership with Roche
    • Sobi: Enable Injections Announces Agreement with Sobi to Develop and Distribute Aspaveli in Combination with enFuse in Sobi Territories

• • Awards & Recognition
    • Fierce Medtech’s Fierce 15
    • Cincinnati Business Courier C-Suite Awards: Tim Flaherty, Chief Financial Officer
    • Fierce Innovation Award: Life Sciences 2024, Drug Delivery Technology
    • Scrip Awards: Business Development Team of the Year Finalists
    •  

• • Facility Expansion
    • Enable Injections Announces Plans to Expand Manufacturing Facilities and Corporate Headquarters

The purpose of Enable Injections is to improve the patient experience through innovative drug delivery technology. Through these partnerships, we can impact patients around the world.

On our journey to make an impact, our culture and our employees are the driving force behind our work. We celebrate the big and small wins, and we’ve had some big accomplishments this year. We’re thankful for the team who is behind everything we do!